At a glance

ClinicalIndex Comparison Record

Phase 4Completed· 20 enrolled

Drug / intervention

Exparel +1 moredrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02011464

NCT02011464Phase 4Completed

Compare CT.gov

Evaluation of the Efficacy of Exparel Delivered Into the Posterior Capsule During Knee Replacement

Maimonides Medical Center·interventional·Posted Dec 13, 2013·Updated Aug 8, 2017

In Brief

A Phase 4 clinical trial evaluating Exparel and Saline for Arthritis. Completed, enrolled 20 participants across 1 site.

Detailed Summary

Pain control after knee replacement requires analgesia to both the top (anterior) and bottom (posterior) portion of the the knee. Presently we use a nerve block for the anterior portion. The investigators want to to examine if giving Exparel into the posterior portion will give better pain relief. Hypothesis: There is no difference in, the use of analgesics or the length and quality of analgesia and no decrease in the time to be able to accomplish simple to complex knee movements using Exparel infiltration when compared to controls.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsArthritis

CountriesUnited States

Collaborators--

Timeline

Phase 4CompletedFinished

2014201520162017201820192020202120222023202420252026

Enrollment StartDec 2013

First PostedDec 2013

Primary CompletionSep 2015

TodayJul 2026

First PostedDec 13, 2013

Enrollment StartDec 1, 2013

Primary CompletionSep 1, 2015

TodayJul 2, 2026

Enrollment to primary: 1.8 yearsPosted 12.6 years ago

Interventions

Expareldrug

Exparel is infiltrated into posterior compartment for pain control

Salineother

Saline is infiltrated into posterior compartment for control